EQUASHIELD® Maintains Top Position in US Pharmacies for Seven Years with CSTD Innovation

EQUASHIELD® Secures #1 Ranking in US Pharmacies for CSTD

EQUASHIELD®, a prominent innovator in Closed System Transfer Devices (CSTDs) and automated compounding solutions, is thrilled to announce its recognition as the top-ranked CSTD in US pharmacies for the seventh straight year, as reported by Pharmacy Purchasing Products. This achievement not only reflects EQUASHIELD®'s dedication to safety, innovation, and efficiency but also highlights the trust that healthcare professionals place in their products to shield against hazardous drug exposure.

Since its inception, EQUASHIELD® has positioned itself as a reliable partner across thousands of healthcare facilities globally, earning the confidence of pharmacy professionals with its state-of-the-art safety features and user-friendly design. Jason Dutcher, the Director of Strategic Accounts at EQUASHIELD®, expressed gratitude towards healthcare professionals, stating, "Our dedication to enhancing safety and efficiency in pharmacy operations remains strong year after year. This achievement underscores that commitment and reflects the trust placed in us by healthcare professionals across the country."

Central to EQUASHIELD®'s success is its groundbreaking closed-back Syringe Unit—a patented design aimed at effectively containing hazardous drug aerosols and vapors during compounding and administration. This unit comes equipped with a pre-bonded connector and an encapsulated plunger rod, augmenting both usability and safety. The design mitigates risks of accidental disconnections, spills, and contamination, thereby ensuring safer handling of hazardous substances within the healthcare sector. Moreover, EQUASHIELD®’s broad range of products addresses significant exposure risks and meets rigorous safety standards, contributing to its extensive adoption in the United States and abroad.

EQUASHIELD® has also significantly advanced its Pharmacy Automation solutions, adapting to technological advancements that streamline the handling and compounding of hazardous drugs. A noteworthy innovation is the EQUASHIELD® Mundus Mini HD, which integrates robotic automation into pharmacy workflows. This enhancement not only minimizes human error but also guarantees precise and contamination-free compounding, thereby providing an additional safety layer for both healthcare workers and patients.

Reflecting on the company's ongoing success, Dutcher remarked, "Seven years at the top is no small feat. This continued success comes from our relentless focus on research and development, listening to our customers, and delivering solutions that address their most pressing needs." With eyes set on the future, EQUASHIELD® continues to commit to driving advancements in healthcare technology while fostering safer environments for all healthcare workers.

For more detailed information on EQUASHIELD® and its revolutionary CSTD and pharmacy automation solutions, please visit www.EQUASHIELD.com.

About EQUASHIELD®

EQUASHIELD® is a leading provider of both manual and automated solutions for the compounding and administration of hazardous drugs. Their CSTD has been clinically validated to protect healthcare professionals from hazardous drug exposure. With a focus on covering more exposure routes than alternative systems, EQUASHIELD® has also proven to meet necessary safety protocols, including the proposed 2015 alcohol vapor containment guideline from NIOSH, confirming its proficiency in containing the harshest vapors. Continuous research and a commitment to improving healthcare safety standards make EQUASHIELD® an essential partner for hospitals and clinics worldwide.